Glial derived neurotrophic factor as a neuroprotective agent

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/18 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2204911

The present invention is directed to the use of glial-derived neurotrophic factor (GDNF) to inhibit or prevent seizure activity. The methods of the present invention are accomplished by administering GDNF to patients having or potentially having a neurodegenerative disorder such as epilepsy. Pharmaceutical compositions containing a therapeutically effective amount of GDNF in a pharmaceutically acceptable carrier are also provided.

L'invention concerne l'utilisation du facteur neurotrophique dérivé des cellules gliales (GDNF) pour inhiber ou prévenir l'activité d'attaque. Les procédés selon l'invention consistent à administrer ledit GDNF à des patients présentant ou susceptibles de présenter des troubles neurodégénératifs tels que l'épilepsie. Des compositions pharmaceutiques contenant une dose thérapeutiquement efficace de GDNF dans un vecteur pharmaceutiquement acceptable sont également décrites.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glial derived neurotrophic factor as a neuroprotective agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glial derived neurotrophic factor as a neuroprotective agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glial derived neurotrophic factor as a neuroprotective agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2055311

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.